Clinical Trials Directory

Trials / Completed

CompletedNCT01015794

Activation of Cervical and Upper Thoracic Brown Adipose Tissue in Humans Via Beta-adrenergic Stimulation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Bayside Health · Other Government
Sex
Male
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

In this study the investigators aim to quantitate the extent of cervical and upper thoracic brown adipose tissue (BAT) activation in lean and obese humans via positron emission tomography-computed tomography (PET-CT) in response to the non-specific beta adrenergic receptor (AR) agonist ephedrine. The investigators hypothesise that this pharmacological adrenergic stimulus will result in activation of BAT in these participants, and that this activation will be reduced in obese patients. This study will provide important preliminary information with respect to allowing the investigators to progress with longer trials with specific beta 3 AR agonists.

Conditions

Interventions

TypeNameDescription
DRUGephedrine hydrochloridesingle oral dose, 1mg/kg body weight
DRUGephedrine hydrochloridesingle dose of 1 mg/kg body weight

Timeline

Start date
2009-12-01
Primary completion
2012-12-01
First posted
2009-11-18
Last updated
2013-02-15

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT01015794. Inclusion in this directory is not an endorsement.